Study supports Iluvien as ‘long-acting option’ in diabetic macular edema
Key takeaways: The NEW DAY study did not meet its primary endpoint but showed good outcomes in secondary endpoints. A post hoc analysis achieved its primary endpoint. LONG BEACH, Calif.…